For the quarter ending 2025-09-30, NAGE made $33,986K in revenue. $4,578K in net income. Net profit margin of 13.47%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Sales, net | 33,986 | 31,117 | 30,481 | |
| Cost of sales | 12,058 | 10,891 | 11,150 | |
| Gross profit | 21,928 | 20,226 | 19,331 | |
| Sales and marketing | 8,768 | 8,207 | 8,117 | |
| Research and development | 1,795 | 1,567 | 1,258 | |
| General and administrative | 7,129 | 7,267 | 5,184 | |
| Total operating expenses | 17,692 | 17,041 | 14,559 | |
| Operating income | 4,236 | 3,185 | 4,772 | |
| Interest income, net | 564 | 552 | 459 | |
| Income before provision for income taxes | 4,800 | 3,737 | 5,231 | |
| Provision for income taxes | 222 | 128 | 168 | |
| Net income | 4,578 | 3,609 | 5,063 | |
| Basic (in dollar per share) | 0.06 | 0.05 | 0.07 | |
| Basic (in shares) | 79,779,000 | 79,249,000 | 77,810,000 | |
| Diluted (in dollar per share) | 0.05 | 0.04 | 0.06 | |
| Diluted (in shares) | 86,619,000 | 86,241,000 | 83,232,000 | |
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE)